Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Placeholder Photo
Samantha Roberts, PhD
GROUP DIRECTOR, US REGULATORY POLICY; CHAIR OF THE BIO PATIENT FOCUSED DRUG DEVELOPMENT TASKFORCE, GENENTECH
Enhancing Meaningful Engagement on Patient Experience Data in Drug Development
Placeholder Photo
Lucas Rocha
CEO, MIRSCIENCE THERAPEUTICS
Mirscience Therapeutics
Dolca Rogers
QUALITY SPECIALIST, EUROPEAN MEDICINES AGENCY
Academic Development of Cell and Gene Therapies: Three Different Perspectives, Including EMA and Academia
Michael Rohr
PARTNER, COOLEY
Investors' Perspectives: Digital Health Trends and Investment Thesis in 2023 and Beyond
Jeff Roix
VENTURE PARTNER AND PORTFOLIO CEO, O2H VENTURES
Psychedelics… the Trip Continues
Kendra Rose, MBA, PhD
SVP AND HEAD OF NEW PLATFORMS, CARDIOVASCULAR AND IMMUNOLOGY, BAYER PHARMACEUTICALS
Creative funding options for biotechs
Placeholder Photo
Inga Rose
FOUNDER & CEO, REFERENCE MEDICINE
Reference Medicine
Luke Rosen
FOUNDER, KIF1A.ORG
Precompetitive Collaborations in Rare Disease Research
New York, New York, United States
Hugh Rosen
PROFESSOR OF MOLECULAR MEDICINE, THE SCRIPPS RESEARCH INSTITUTE
Navigating the Neurodegenerative Diseases Labyrinth: Perspectives from Academia, Biotech, and Pharma
La Jolla, California, United States
David Ross
AZ LEAD FOR ACCUMULUS SYNERGY - BUSINESS TRANSFORMATION, ORSSE, ASTRAZENECA
Re-Imagining Drug Development and Regulatory Submissions through Cloud-Based Technologies